Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

M H Kollef1

  • 1Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, MO 63110, USA. mkollef@pulmonary.wustl.edu

Insights

Inadequate antimicrobial treatment contributes to antibiotic resistance. Strategies like consulting specialists and using guidelines can improve treatment effectiveness for hospital-acquired infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Hospital Epidemiology

Background:

  • Inadequate antimicrobial treatment is a key driver for the emergence of antibiotic-resistant bacteria.
  • Several factors in hospitalized patients, including prior antibiotic use and invasive devices, contribute to inadequate treatment.
  • Understanding these factors is crucial for developing effective antimicrobial stewardship strategies.

Purpose of the Study:

  • To highlight the significance of inadequate antimicrobial treatment in the rise of antibiotic resistance.
  • To identify factors contributing to inadequate treatment in hospitalized patients.
  • To propose strategies for minimizing inadequate antimicrobial treatment and improving patient outcomes.

Main Methods:

  • Review of factors contributing to inadequate antimicrobial treatment in hospitalized patients.
  • Identification of strategies to minimize inadequate treatment, including specialist consultation and guideline adherence.
  • Emphasis on understanding local pathogen prevalence and antibiotic susceptibility.

Main Results:

  • Prior antibiotic exposure, broad-spectrum antibiotic use, prolonged hospitalization, mechanical ventilation, and invasive devices are associated with inadequate treatment.
  • Consulting infectious disease specialists, utilizing antibiotic practice guidelines, and rapid microbiological identification can improve treatment.
  • Tailoring empirical combination therapy based on patient characteristics and local flora, followed by de-escalation, is recommended.

Conclusions:

  • Minimizing inadequate antimicrobial treatment is essential to combat antibiotic resistance.
  • Implementing strategies such as specialist consultation, guideline use, and tailored empirical therapy can enhance antimicrobial effectiveness.
  • Further research is needed to evaluate the impact of these strategies on patient outcomes.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...